Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Systemic medical ozone has proved to help in several viral diseases, chronic obstructive pulmonary disease and chronic inflammation process. The investigators are sure that its application to COVID-19 patients, as an adjuvant therapy, will improve the health status of these individuals.
Epistemonikos ID: 2b1fa28fdd8042ca50d94b2c0543eec806558bc4
First added on: Apr 25, 2020